The 11th Neurotalk’s Brain Health Conference (NBHC-2021)

Submission Guideline

1. The organizers of NBHC-2021 welcome all abstracts within the scope of the meeting. Submitted abstracts will be reviewed by experts and be scheduled for either oral or poster presentation during the congress if the topic is relevant and the quality of the data justifies scheduling. Irrelevant or poor-quality abstracts may be rejected.

2. An Abstracts can be submitted online through the congress website. It is advisable to prepare the complete text of your abstract as well as any figures/tables before accessing online abstract submission.

3. Abstracts need to written in clear English, taking into account the specifications below.

a. Maximum word count of abstract title: 20 words.

b. Maximum word count of abstract text: 350 words (adjust in case of tables/figures).

c. Abstract topic should be selected during the online submission process from the list of predefined topics to facilitate abstract review and scheduling.

d. A minimum of three specific keywords should be added during online submission for indexing of the abstract. Specific keywords are: name(s) of drug(s) investigated, molecular target molecule(s), disease(s) studied, biochemical or biological function(s) studied. Avoid the use of vague keywords, such as: angiogenesis, cell death, cancer, tumor, drug development, drug therapy. The Organizing Committee of NBHC-2021 reserves the rights to delete, edit, or add keywords to achieve uniformity throughout abstract publications.

e. Use International Nonproprietary Names (INN) or research codes to identify drugs throughout the abstract. Proprietary names may be used in the abstract text, not the abstract title. The first time the drug is mentioned use the INN and put proprietary names between brackets.

f. The identity of a new, previously unpublished drug substance should be disclosed in the abstract, either by providing its structural formula or its full chemical name


4. Abstracts will be published exactly as submitted. No editing of abstract texts will be done. However, non-adherence to the above guidelines may be corrected (e.g. use of drug names, keywords) by the meeting organizers.

5. After submission, abstracts can no longer be changed by the authors. Should minor changes be necessary after submission, the author should notify Anna at anna-neurotalk@eventcomittee.com, describing exactly the nature of the change to be made. The NBHC-2021 organizers will then implement the change. If major changes are required the author should submit a revised abstract as an entirely new abstract and send a request to anna-neurotalk@eventcomittee.com to delete the original abstract. The addition of a co-author constitutes a major change.

6. After completion of the abstract review, the submitting author will receive scheduling information via email. Abstracts cannot be withdrawn after receipt of the scheduling information by the submitting author. The presenting author must be registered as a participant of NBHC-2021 for final scheduling and publication of the abstract.

7. Accepted abstracts will be published in the Conference Proceedings. The authors of the submitted abstracts are responsible for any Intellectual Property issues concerning the abstracts on their own. The organizing committee of NBHC-2021 reserves the right to use submitted abstracts for conference purposes.

 

Online Registration
News Released
Speaking Proposals Are Now Being Accepted
Call for Exhibitors and Sponsors
Call for Collaborative
World Class Meeting Venue

NBHC-2021 will be celebrated at Dalian International Conference Center, China

Hosting Organization

International Alzheimer Industry Alliance

Operating Organizations

SHUANGDI•ZHEN-AOHEATH INDUSTRY GROUP

Goldstone Innovation Institute

Renowned Speakers of Previous Events


Dr. Zang-Hee Cho,
Professor, Neuroscience Research Institute, The University of Suwon, South Korea


Dr. George R. Lee,
Past President, American Society of Neurophysiological Monitoring, USA


Dr. Guy R Seabrook,
Vice President & Global Lead, Neuroscience External Innovation, Janssen Research & Development, Johnson & Johnson Innovation, South San Francisco, USA


Dr. John Nicholas Pepys Rawlins,
Pro-Vice-Chancellor, the University of Oxford, UK; Professor, Chinese University of Hong Kong, Hong Kong, China


Dr. Jianguo Cheng,
President, American Academy of Pain Medicine; Professor and Director, Cleveland Clinic Multidisciplinary Pain Medicine FellowshipCleveland Clinic, USA


Dr. Yang D. Teng,
President, The American Society for Neural Therapy and Repair, USA


Dr. Niall T M Galloway,
Associate Professor, Emory University, USA


Dr. Francisco Fernandez Nistal,
CEO, Asociacion de Dano Cerebral de Navarra (ADACEN), Spain


Dr. Yukio Yoneda,
Professor Emeritus, Kanazawa University, Japan


Dr. Hsiao-Yuan Lee,
Distinguished Research Fellow, Institute of Biomedical Sciences, Academia Sinica, Taiwan


Dr. Jianwu Dang,
Professor, Japan Advanced Institute of Science and Technology, Japan


Dr. Florence Levy,
Head, Prince of Wales Hospital, Australia


Dr. April R Wiechmann,
Director, Neuropsychology Clinic, Associate Professor, University of North Texas Health Science Center, USA


Dr. Lakshmi D. Katikaneni,
Professor, Medical University of South Carolina, USA


Dr. Kwoon Y. Wong,
Associate Professor, University of Michigan, USA


Dr. Jozsef Zoltan Kiss,
Professor, University of Geneva Medical School, Switzerland


Dr. David R. Gater,
Professor, Penn State College of Medicine, USA


Dr. Yumin Zhang,
Associate Professor, Uniformed Services University, USA


Dr. Leo Petrossian,
CEO Neural Analytics, USA


Dr. Alberto de Bellis,
Founder & President, Maria Rosaria Maglione Foundation Onlus, Italy


Dr. Stefan Strotzka,
Professor, Geronto-Psychiatric Center for Psychosocial Services in Vienna, Austria


Dr. Fumisuke Matsuo,
Clinical Professor, University of Utah, USA


Dr. Andrew Worthington,
Director, Headwise, UK


Dr. Anna Cornelia Beyer,
Senior Lecturer, University of Hull, UK


Dr. Drew A. Nagele,
Clinical Professor, Philadelphia College of Osteopathic Medicine, USA


Dr. Chuk-ling Julian Lai,
Associate Professor, City University of Hong Kong, Hong Kong, China


Dr. Gabrielle Todd,
Associate Professor, University of South Australia, Australia


Dr. Weiya Ma,
Assistant Professor, University of McGill, Canada


Dr. Istvan J.E. Boksay,
Clinical Professor, New York University, USA


Dr. Shaobai Zhang,
Professor, Nanjing University of Posts and Telecommunications, China


Dr. Cai Song,
Professor, Director, Institute for Marine Drugs and Nutrition; Director, Marine Medicine Develop.Cent. Shenzhen Institute; Guangdong Ocean University, China

 
©2010-2021 All right reserved by BIT Congress Inc.
Tel: +86-411-8479 9609-816, Fax: +86-411-8479 6897